Literature DB >> 28210385

High-dose Rate Electronic Brachytherapy: A Nonsurgical Treatment Alternative for Nonmelanoma Skin Cancer.

Ajay Bhatnagar1, Rakesh Patel2, William Philip Werschler3, Roger I Ceilley4, Robert Strimling5.   

Abstract

The authors summarized data from a group of physicians with experience using high-dose rate electronic brachytherapy for the treatment of nonmelanoma skin cancer. The data have been published or presented in abstract format at national dermatology and radiation oncology meetings. The data included 1,822 treated lesions from 2009 to 2014 in patients ranging in age from 52 to 104 years. Most lesions were basal cell carcinoma (57%) or squamous cell carcinoma (38%) less than 2cm in size (97%). Median follow-up at the various centers ranged from 4 to 16 months, and results yielded an extremely low recurrence rate of less than one percent. Results show that within the confines of this follow up period, electronic brachytherapy is an effective, convenient, nonsurgical treatment option for patients with nonmelanoma skin cancer with few recurrences and excellent cosmetic results.

Entities:  

Year:  2016        PMID: 28210385      PMCID: PMC5300713     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  25 in total

1.  Outcome of 110 basal cell carcinomas of the eyelid treated with frozen section-controlled excision: mean follow-up over 5 years.

Authors:  Antonio Giordano Resti; Riccardo Sacconi; Nicola Baccelli; Francesco Bandello
Journal:  Eur J Ophthalmol       Date:  2013-12-05       Impact factor: 2.597

2.  Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.

Authors:  Anthony J Paravati; Peter G Hawkins; Amanda N Martin; Gina Mansy; Doug A Rahn; Sunil J Advani; Jeremy Hoisak; Irena Dragojevic; Peter J Martin; Charles J Miller; Parag Sanghvi
Journal:  Pract Radiat Oncol       Date:  2015-07-17

3.  Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden.

Authors:  A M Wennberg; O Larkö; B Stenquist
Journal:  Acta Derm Venereol       Date:  1999-09       Impact factor: 4.437

4.  Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.

Authors:  Igal Leibovitch; Shyamala C Huilgol; Dinesh Selva; Dudley Hill; Shawn Richards; Robert Paver
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

Review 5.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

Authors:  D E Rowe; R J Carroll; C L Day
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

6.  Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.

Authors:  Lesley E Rhodes; Menno A de Rie; Ragna Leifsdottir; Raymond C Yu; Ingeborg Bachmann; Victoria Goulden; Gavin A E Wong; Marie-Aleth Richard; Alex Anstey; Peter Wolf
Journal:  Arch Dermatol       Date:  2007-09

Review 7.  Mohs micrographic surgery for the management of nonmelanoma skin cancers.

Authors:  Lara Cumberland; Ali Dana; Nanette Liegeois
Journal:  Facial Plast Surg Clin North Am       Date:  2009-08       Impact factor: 1.918

8.  Mohs micrographic surgery local recurrences.

Authors:  G J Hruza
Journal:  J Dermatol Surg Oncol       Date:  1994-09

9.  Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose.

Authors:  Z Petrovich; H Kuisk; B Langholz; M Astrahan; G Luxton; L Chak; D Rice
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

10.  Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice.

Authors:  Stephen Doggett; Mark Willoughby; Cole Willoughby; Erick Mafong; Amy Han
Journal:  J Clin Aesthet Dermatol       Date:  2015-11
View more
  6 in total

1.  Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy.

Authors:  S Rodríguez; M Arenas; C Gutierrez; J Richart; J Perez-Calatayud; F Celada; M Santos; A Rovirosa
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

2.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.

Authors:  Jo Ann LeQuang
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

Review 3.  The State of the Art of Radiotherapy for Non-melanoma Skin Cancer: A Review of the Literature.

Authors:  Sofian Benkhaled; Dirk Van Gestel; Carolina Gomes da Silveira Cauduro; Samuel Palumbo; Veronique Del Marmol; Antoine Desmet
Journal:  Front Med (Lausanne)       Date:  2022-06-27

4.  Extensive Cutaneous T-Cell Lymphoma of the Feet Treated with High-Dose-Rate Brachytherapy and External Beam Radiation.

Authors:  Joy Tao; Courtney Hentz; Michael L Mysz; Issra Rashed; David Eilers; James Swan; Rebecca Tung; Bahman Emami
Journal:  Case Rep Dermatol Med       Date:  2018-08-07

Review 5.  Management of keratinocyte carcinoma - Special considerations in the elderly.

Authors:  Alison Bailey; Brooke Vasicek; Joy Tao; Monica Janeczek; Andia Mitri; Rebecca Tung
Journal:  Int J Womens Dermatol       Date:  2019-05-18

6.  High-resolution, ultrasound-guided, high-dose-rate, surface brachytherapy for basal cell carcinoma of the skin: A case report.

Authors:  Simeng Zhu; Xiaofeng Yang; Karen M Xu; Jiwoong Jason Jeong; Mohammad K Khan
Journal:  Adv Radiat Oncol       Date:  2018-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.